Browsing: Science
The mystery reaches far beyond understanding how neurons process information. Scientists can observe which parts of the brain become active when a person sees an object, feels pain, recalls a memory, or makes a decision. Yet they still cannot explain why those physical processes are accompanied by an inner experience.
Plus: Anthropic says its AI models hacked external organizations during testing.
The mystery reaches far beyond understanding how neurons process information. Scientists can observe which parts of the brain become active when a person sees an object, feels pain, recalls a memory, or makes a decision. Yet they still cannot explain why those physical processes are accompanied by an inner experience.
Plus: Anthropic says its AI models hacked external organizations during testing.
The mystery reaches far beyond understanding how neurons process information. Scientists can observe which parts of the brain become active when a person sees an object, feels pain, recalls a memory, or makes a decision. Yet they still cannot explain why those physical processes are accompanied by an inner experience.
The state’s effort to expand the “right to try” is making headway, and the first drugs are about to be reviewed.
The mystery reaches far beyond understanding how neurons process information. Scientists can observe which parts of the brain become active when a person sees an object, feels pain, recalls a memory, or makes a decision. Yet they still cannot explain why those physical processes are accompanied by an inner experience.
The state’s effort to expand the “right to try” is making headway, and the first drugs are about to be reviewed.
The mystery reaches far beyond understanding how neurons process information. Scientists can observe which parts of the brain become active when a person sees an object, feels pain, recalls a memory, or makes a decision. Yet they still cannot explain why those physical processes are accompanied by an inner experience.
The state’s effort to expand the “right to try” is making headway, and the first drugs are about to be reviewed.
